Fresenius SE & Co. KGaA

Business & Finance - 2008

22.12.2008	HELIOS awarded two hospital privatization projects in Germany
	Text as PDF-file
02.12.2008	Capital Market Day: Fresenius Helios and Fresenius Vamed poised for continued growth
	Text as PDF-file
30.09.2008	Syndicated Credit Facilities for APP Pharmaceuticals acquisition financing increased by US$ 500 million due to strong demand
	Text as PDF-file
16.09.2008	Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
	Text as PDF-file
10.09.2008	Fresenius closes APP acquisition
	Text as PDF-file
02.09.2008	Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
	Text as PDF-file
28.08.2008	Moody’s confirms Fresenius SE’s Ba1 rating
	Text as PDF-file
12.08.2008	Fresenius SE successfully completes capital increase
	Text as PDF-file
11.08.2008	Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities
	Text as PDF-file
11.08.2008	Fresenius resolves on capital increase
	Text as PDF-file
11.08.2008	Acquisition of Dabur Pharma successfully closed
	Text as PDF-file
17.07.2008	Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA
	Text as PDF-file
17.07.2008	Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care
	Text as PDF-file
09.07.2008	Fresenius Medical Care Signs Agreements for Intravenous Iron Products
	Text as PDF-file
07.07.2008	Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
	Text as PDF-file
06.06.2008	Fresenius Group donates over US$ 1.5 million in aid for victims of earthquake in China
	Text as PDF-file
21.05.2008	Annual General Meeting of Fresenius SE: Fresenius Confirms Positive Outlook for 2008 – 15th Consecutive Dividend Increase Approved
20.05.2008	Fresenius Medical Care Reports Strong Start for 2008 - Shareholders Approve Eleventh Consecutive Annual Dividend Increase
	Text as PDF-file
20.05.2008	Moody's Rating of Fresenius Medical Care AG & Co. KGaA upgraded to Ba1
	Text as PDF-file
20.05.2008	Moody’s upgrades rating of Fresenius SE to Ba1
	Text as PDF-file
20.04.2008	Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics
	Text as PDF-file
07.04.2008	Fresenius Medical Care announces status in Patent Case
	Text as PDF-file
02.04.2008	Fresenius Medical Care Announces upgraded Rating of Unsecured Debt Issues by Standard & Poor’s
	Text as PDF-file
29.01.2008	Portugal to Introduce a Bundled Rate for Hemodialysis Treatment
	Text as PDF-file
25.01.2008	Fresenius Medical Care Extends Senior Note Exchange Offer
	Text as PDF-file
11.01.2008	Fresenius Medical Care Selected To Provide Dialysis Care to More than 400 Patients in the U.K.
	Text as PDF-file

Home > Press > Press Releases > Business & Finance > 2008